Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

6,128 public trials 1,241 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Recruiting

Vorasidenib Maintenance for IDH Mutant Astrocytoma

NCT06809322

Conditions
Astrocytoma, Glioma, IDH-mutant Grade 2 or 3 Astrocytoma, +7 more
Locations
  • Medical University of Innsbruck Innsbruck, Austria
  • Kepler University Hospital - Neuromed campus Linz, Austria
  • Medical University of Vienna Vienna, Austria
  • Universitair Ziekenhuis Brussel Brussels, Belgium
View all 33 locations
View Trial Details
Recruiting

Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention

NCT07649681

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Digestive System Diseases, +42 more
Locations
  • Universitätsklinikum Augsburg Augsburg, Bavaria, Germany
  • Universitätsklinikum Erlangen Erlangen, Bavaria, Germany
  • LMU Klinikum Krebszentrum - CCC MünchenLMU - Comprehensive Cancer Center München, Bavaria, Germany
  • Klinikum der Technischen Universität München (TUM Klinikum) München, Bavaria, Germany
View Trial Details
Recruiting

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

NCT06860594

Conditions
Astrocytoma, Astrocytoma, IDH-Mutant, Grade 2, Glioblastoma, +22 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 43 locations
View Trial Details
Recruiting

TheraSphere Japan Pre-Market Study

NCT07377487

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +24 more
Locations
  • Hyogo College of Medicine Hospital Nishinomiya, Hyōgo, Japan
  • Kanazawa University Hospital Kanazawa, Ishikawa-ken, Japan
  • Kindai University Hospital Sayama, Osaka, Japan
  • National Cancer Center Hospital Chuo Ku, Tokyo, Japan
View Trial Details
Recruiting

EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

NCT06556563

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
View all 102 locations
View Trial Details

Related conditions